Physician

John Matthew Mcdonald

According to 2025 Medicare claims, John Mcdonald (NPI: 1467496869) practices gynecologist/oncologist in the Charlotte-Concord-Gastonia, NC-SC market, with the plurality of this provider's patient population coming from Mecklenburg, NC. This provider's primary affiliated billing organization is THE PRESBYTERIAN HOSPITAL (NPI: 1275256422; TIN: 560554230) and primary practice location at 28204-3215.

Mcdonald's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 84 traditional Medicare patients, billed 486 HCPCS/CPT codes, and received $41,497 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 106 prescription claims across 40 beneficiaries totaling $115,285 in drug costs, led by Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen). DME data shows 36 claims. Open Payments data shows 3 records totaling $613. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $7,434 and ending at $115,285. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	226	585	$76,441
2016	194	407	$61,032
2017	142	279	$31,945
2018	154	331	$46,866
2019	121	298	$42,686
2020	109	344	$44,800
2021	94	307	$46,147
2022	99	357	$50,239
2023	95	341	$45,870
2024	84	486	$41,497

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	99	266	$7,434
2016	78	249	$53,982
2017	63	163	$13,324
2018	61	151	$21,779
2019	54	140	$54,203
2020	53	120	$60,278
2021	46	138	$27,256
2022	49	135	$64,270
2023	46	103	$12,514
2024	40	106	$115,285

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	77	$6,604
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	24	$1,067
2024	N/R	36	$1,090

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	19	19	$121
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	27	119	$102
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	37	50	$64
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	19	21	$40
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	61	150	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	43	$71
Estradiol	Estradiol	11	556	$29

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8530	Cyclophosphamide; oral, 25 mg	N	N/R	18	$752
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	18	$339

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$613	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for John Matthew Mcdonald?

Tedicare shows public-source Medicare data for John Matthew Mcdonald (NPI 1467496869), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John Matthew Mcdonald have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to John Matthew Mcdonald?

John Matthew Mcdonald is linked to THE PRESBYTERIAN HOSPITAL (billing NPI 1275256422) in the available physician profile data.

Does John Matthew Mcdonald have Open Payments data?

John Matthew Mcdonald has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.